Evidence map›Paper›PMID 20862503›Full record

ArticleClinical rheumatology2013

Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis.

Cord Huchzermeyer, Christian Mardin, Leonard Holbach, Jochen Zwerina, Georg Schett, Jürgen Rech

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Mycobacterium W administration for steroid resistant optic neuritis with long-term follow-up.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2014
    Article
  7. Inflammatory optic neuropathies.Continuum (Minneapolis, Minn.) · 2014
    Review
  8. Outcomes of toll-like receptors' antagonism in steroid-resistant optic neuritis; a pilot study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2012
    Article
  9. Current options for the treatment of optic neuritis.Clinical ophthalmology (Auckland, N.Z.) · 2012
    Article
  10. Magnetic resonance imaging of optic nerve.The Indian journal of radiology & imaging
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Cord HuchzermeyerDepartment of Ophthalmology, University of Erlangen-Nuremberg, Erlangen, Germany. Cord.Huchzermeyer@uk-erlangen.de
Christian Mardin
Leonard Holbach
Jochen Zwerina
Georg Schett
Jürgen Rech
Friedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 56-year old patient with a history of limited Wegener's granulomatosis presented with signs and symptoms of optic neuritis. Radiologic signs of orbital inflammation were absent. Testing of visual acuity and visual field allowed close monitoring of disease activity. Thus, rapid improvement of visual function was achieved with high-dose steroids. Despite maintenance therapy with cyclophosphamide recurrence occurred repeatedly as soon as tapering of steroids was begun. After remission induction with rituximab, the patient retained good visual function under maintenance therapy with azathioprine and low-dose corticosteroids. Optic neuritis in Wegener's granulomatosis without signs of orbital involvement is rare and most likely caused by occlusive vasculitis of the vasa nervorum. In this patient with optic neuritis refractory to conventional therapy, rituximab in combination with cyclophosphamide and corticosteroids was well tolerated and successfully used for remission induction, followed by maintenance therapy with azathioprine and low dose corticosteroids.

Indexed as

Antibodies, Monoclonal, Murine-DerivedAzathioprineCyclophosphamideDose-Response Relationship, DrugDrug ResistanceDrug Therapy, CombinationFemaleGlucocorticoidsGranulomatosis with PolyangiitisHumansImmunosuppressive AgentsMiddle AgedOptic NeuritisRemission InductionRituximabTreatment OutcomeAntibodies, Monoclonal, Murine-DerivedAzathioprineCyclophosphamideGlucocorticoidsImmunosuppressive AgentsRituximab

Identifiers

PMID20862503
OpenAlexW2016488688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.